Melasma is a recurrent and treatment-resistant hyperpigmentation disorder characterized by a complex and multifactorial pathogenesis. However, the lack of a stable and reliable animal model has hindered systematic investigations into its onset and progression. In this study, we established a melasma-like model in C57BL/6J mice by combining broadband UVB irradiation, intramuscular progesterone administration, and induced emotional stress. The affected skin areas exhibited irregular, brown hyperpigmented patches. Histopathological analysis revealed an accumulation of melanin granules in the epidermis and superficial dermis, elevated levels of tyrosinase (TYR) in both skin and plasma, systemic oxidative stress imbalance, and reduced autophagic activity in the lesional skin. Furthermore, this model displayed distinct differences from a UV-induced post-inflammatory hyperpigmentation (PIH) model. Notably, the melasma-like mice responded to tranexamic acid treatment in a manner that closely resembled clinical outcomes observed in human patients. Collectively, these findings establish a stable, reproducible, and clinically relevant mouse model of melasma, providing a valuable platform for future research into its pathogenesis and treatment.
| [1] |
R. Sarkar, A. Bansal, and P. Ailawadi, “Future Therapies in Melasma: What Lies Ahead?,” Indian Journal of Dermatology, Venereology and Leprology 86 (2020): 8–17.
|
| [2] |
S. H. Kwon, Y. J. Hwang, S. K. Lee, et al., “Heterogeneous Pathologyof Melasma and Its Clinical Implications[J],” International Journal of Molecular Sciences 17 (2016): 824.
|
| [3] |
A. C. Handel, P. B. Lima, V. M. Tonolli, L. D. Miot, and H. A. Miot, “Risk Factors for Facial Melasma in Women: A Case-Control Study,” British Journal of Dermatology 171 (2014): 588–594.
|
| [4] |
T. Passeron and M. Picardo, “Melasma, a Photoaging Disorder,” Pigment Cell & Melanoma Research 31, no. 4 (2018): 461–465.
|
| [5] |
Z. J. Yang and J. Lu, “Mechanisms of Ultraviolet-Induced Melasma Formation: A Review,” Journal of Dermatology 49, no. 12 (2022): 1201–1210.
|
| [6] |
N. F. Goandal, J. Rungby, and K. E. Karmisholt, “The Role of Sex Hormones in the Pathogenesis of Melasma[J],” Ugeskrift for Laeger 184, no. 6 (2022): V10210769.
|
| [7] |
A. Tamega Ade, H. A. Miot, N. P. Moço, et al., “Gene and Protein Expression of Oestrogen-β and Progesterone Receptors in Facial Melasma and Adjacent Healthy Skin in Women[J],” International Journal of Cosmetic Science 37, no. 2 (2015): 222–225.
|
| [8] |
A. Y. Lee, “Recent Progress in Melasma Pathogenesis,” Pigment Cell & Melanoma Research 28, no. 6 (2015): 648–660.
|
| [9] |
M. Cario, “How Hormones May Modulate Human Skin Pigmentation in Melasma: An In Vitro Perspective,” Experimental Dermatology 28, no. 6 (2019): 709–718.
|
| [10] |
A. Filoni, M. Mariano, and N. Cameli, “Melasma: How Hormones Can Modulate Skin Pigmentation,” Journal of Cosmetic Dermatology J 18, no. 2 (2019): 458–463.
|
| [11] |
W. Liu, Q. Chen, and Y. Xia, “New Mechanistic Insights of Melasma[J],” Clinical, Cosmetic and Investigational Dermatology 16 (2023): 429–442. Published 2023 Feb 13.
|
| [12] |
S. Katiyar and D. Yadav, “Correlation of Oxidative Stress With Melasma: An Overview,” Current Pharmaceutical Design 28 (2022): 225–231.
|
| [13] |
H. Y. Secßkin, G. Kalkan, Y. Basß, et al., “Oxidative Stress Status in Patients With Melasma[J],” Cutaneous and Ocular Toxicology 33 (2014): 212–217.
|
| [14] |
X. Zhang, B. S. Rosenstein, Y. Wang, M. Lebwohl, and H. Wei, “Identification of Possible Reactive Oxygen Species Involved in Ultraviolet Radiation-Induced Oxidative DNA Damage,” Free Radical Biology and Medicine 23 (1997): 980–985.
|
| [15] |
V. Choubey, R. Sarkar, V. Garg, S. Kaushik, S. Ghunawat, and S. Sonthalia, “Role of Oxidative Stress in Melasma: A Prospective Study on Serum and Blood Markers of Oxidative Stress in Melasma Patients,” International Journal of Dermatology 56 (2017): 939–943.
|
| [16] |
F. Ma, O. Plazyo, A. C. Billi, et al., “Single Cell and Spatial Sequencing Define Processes by Which Keratinocytes and Fibroblasts Amplify Inflammatory Responses in Psoriasis,” Nature Communications 14, no. 1 (2023): 3455.
|
| [17] |
D. G. Janson, G. Saintigny, A. van Adrichem, C. Mahé, and A. El Ghalbzouri, “Different Gene Expression Patterns in Human Papillary and Reticular Fibroblasts,” Journal of Investigative Dermatology 132, no. 11 (2012): 2565–2572.
|
| [18] |
H. He, H. Suryawanshi, P. Morozov, et al., “Single-Cell Transcriptome Analysis of Human Skin Identifies Novel Fibroblast Subpopulation and Enrichment of Immune Subsets in Atopic Dermatitis,” Journal of Allergy and Clinical Immunology 145, no. 6 (2020): 1615–1628.
|
| [19] |
W. Liu, Q. Chen, and Y. Xia, “New Mechanistic Insights of Melasma[J],” Clinical, Cosmetic and Investigational Dermatology 16 (2023): 429–442.
|
| [20] |
F. Ma, T. K. Hughes, R. M. B. Teles, et al., “The Cellular Architecture of the Antimicrobial Response Network in Human Leprosy Granulomas,” Nature Immunology 22, no. 7 (2021): 839–850.
|
| [21] |
A. C. C. Espósito, N. P. de Souza, L. D. B. Miot, et al., “Deficit in Autophagy: A Possible Mechanism Involved in Melanocyte Hyperfunction in Melasma[J],” Indian Journal of Dermatology, Venereology and Leprology Published online April 12 (2021): 1–3.
|
| [22] |
J. Shen, J. Jin, J. Huang, Y. Guo, and Q. Qian, “Combining Large-Spot Low-Fluence 1064-Nm and Fractional 1064-Nm Picosecond Lasers for Promoting Protective Melanosome Autophagy via the PI3K/Akt/mTOR Signalling Pathway for the Treatment of Melasma,” Experimental Dermatology 33, no. 5 (2024): e15094.
|
| [23] |
D. Murase, A. Kusaka-Kikushima, A. Hachiya, et al., “Autophagy Declines With Premature Skin Aging Resulting in Dynamic Alterations in Skin Pigmentation and Epidermal Differentiation,” International Journal of Molecular Sciences 21, no. 16 (2020): 5708.
|
| [24] |
W. Liu, Q. Chen, and Y. Xia, “New Mechanistic Insights of Melasma[J],” Clinical, Cosmetic and Investigational Dermatology 16 (2023): 429–442.
|
| [25] |
X. Sun, W. Wang, H. Yang, et al., “A Comparative Study on the Sensitivity of Establishing Melasma-Like Models in Different Strains of Mice,” Journal of Cosmetic Dermatology 24, no. 4 (2025): e70155.
|
| [26] |
C. Herraiz, J. C. Garcia-Borron, C. Jiménez-Cervantes, and C. Olivares, “MC1R Signaling. Intracellular Partners and Pathophysiological Implications[J],” Biochimica et Biophysica Acta - Molecular Basis of Disease 1863, no. 10 Pt A (2017): 2448–2461.
|
| [27] |
S. Katiyar and D. Yadav, “Correlation of Oxidative Stress With Melasma: An Overview,” Current Pharmaceutical Design 28, no. 3 (2022): 225–231.
|
| [28] |
Y. Gu, F. Xue, H. Xiao, L. Chen, and Y. Zhang, “Bamboo Leaf Flavonoids Suppress Oxidative Stress-Induced Senescence of HaCaT Cells and UVB-Induced Photoaging of Mice Through p38 MAPK and Autophagy Signaling,” Nutrients 14 (2022): 793.
|
| [29] |
V. Choubey, R. Sarkar, V. Garg, S. Kaushik, S. Ghunawat, and S. Sonthalia, “Role of Oxidative Stress in Melasma: A Prospective Study on Serum and Blood Markers of Oxidative Stress in Melasma Patients,” International Journal of Dermatology 56, no. 9 (2017): 939–943.
|
| [30] |
R. Sarkar, P. Ailawadi, and S. Garg, “Melasma in Men: A Review of Clinical, Etiological, and Management Issues,” Journal of Clinical and Aesthetic Dermatology 11, no. 2 (2018): 53–59.
|
| [31] |
Y. Gu, J. Han, C. Jiang, and Y. Zhang, “Biomarkers, Oxidative Stress and Autophagy in Skin Aging,” Ageing Research Reviews 59 (2020): 101036.
|
| [32] |
M. Rinnerthaler, J. Bischof, M. K. Streubel, et al., “Oxidative Stress in Aging Human Skin[J],” Biomolecules 5, no. 2 (2015): 545–589.
|
| [33] |
H. Konisky, E. Balazic, J. A. Jaller, U. Khanna, and K. Kobets, “Tranexamic Acid in Melasma: A Focused Review on Drug Administration Routes[J],” Journal of Cosmetic Dermatology 22, no. 4 (2023): 1197–1206.
|
| [34] |
O. Artzi, T. Horovitz, E. Bar-Ilan, et al., “The Pathogenesis of Melasma and Implications for Treatment,” Journal of Cosmetic Dermatology 20, no. 11 (2021): 3432–3445.
|
| [35] |
B. J. Doolan and M. Gupta, “Melasma,” Australian Journal of General Practice 50, no. 12 (2021): 880–885.
|
| [36] |
M.-s. Miao, Z.-n. Fu, and L.-h. Cao, “Specifications for the Preparation of Animal Models of Melasma (Draft),” Traditional Chinese Drug Research & Clinical Pharmacology 28, no. 5 (2017): 649–653.
|
| [37] |
S. Rajanala, M. B. Maymone, and N. A. Vashi, “Melasma Pathogenesis: A Review of the Latest Research, Pathological Findings, and Investigational Ther-Apies,” Dermatology Online Journal 25 (2019): 25.
|
| [38] |
W. Liu, Q. Chen, and Y. Xia, “New Mechanistic Insights of Melasma [J],” Clinical, Cosmetic and Investigational Dermatology 16 (2023): 429–442.
|
| [39] |
A. Iddamalgoda, Q. T. Le, K. Ito, et al., “Mast Cell Tryptase and Photoaging: Possible Involvement in the Degradation of Extra Cellular Matrix and Basement Membrane Proteins [J],” Archives of Dermatological Research 300, no. Suppl 1 (2008): S69–S76.
|
| [40] |
L. M. Coussens, W. W. Raymond, G. Bergers, et al., “Inflammatory Mast Cells Up-Regulate Angiogenesis During Squamous Epithelial Carcinogenesis,” Genes & Development 13 (1999): 1382–1397.
|
| [41] |
W. H. Kang, K. H. Yoon, E. S. Lee, et al., “Melasma:Histopathological Characteristics in 56 Korean Patients,” British Journal of Dermatology 146 (2002): 228–237.
|
| [42] |
A. C. C. Espósito, G. Brianezi, N. P. de Souza, L. D. B. Miot, and H. A. Miot, “Exploratory Study of Epidermis, Basement Membrane Zone, Upper Dermis Alterations and Wnt Pathway Activation in Melasma Compared to Adjacent and Retroauricular Skin,” Annals of Dermatology 32, no. 2 (2020): 101–108.
|
| [43] |
F. Hafeez, D. A. Mata, C. G. Lian, D. . A. Mata, C. . G. Lian, and E. . G. Poulos, “Prominent Transepidermal Melanin Deposition Is a Distinguishing Histopathological Feature of Melasma: A Clinicopathologic Study,” Dermatology 237, no. 1 (2021): 145–147.
|
| [44] |
A. C. C. Espósito, G. Brianezi, N. P. de Souza, D. C. Santos, L. D. B. Miot, and H. A. Miot, “Ultrastructural Characterization of Damage in the Basement Membrane of Facial Melasma,” Archives of Dermatological Research 312, no. 3 (2020): 223–227.
|
| [45] |
N. H. Kim and A. Y. Lee, “Oxidative Stress Induces Skin Pigmentation in Melasma by Inhibiting Hedgehog Signaling,” Antioxidants (Basel) [J] 12, no. 11 (2023): 1969 Published 2023 Nov 6.
|
| [46] |
R. Sarkar, S. Devadasan, V. Choubey, and B. Goswami, “Melatonin and Oxidative Stress in Melasma - An Unexplored Territory; a Prospective Study,” International Journal of Dermatology 59, no. 5 (2020): 572–575.
|
| [47] |
N. M. K. Spierings, “Melasma: A Critical Analysis of Clinical Trials Investigating Treatment Modalities Published in the Past 10 Years,” Journal of Cosmetic Dermatology 19, no. 6 (2020): 1284–1289.
|
| [48] |
K. Maeda and Y. Tomita, “Mechanism of the Inhibitory Effect of Tranexamic Acid on Melanogenesis in Cultured Human Melanocytes in the Presence of Keratinocyte-Conditioned Medium,” Journal of Health Science 53, no. 4 (2007): 389–396.
|
| [49] |
S. O. Tawfic, R. M. Abdel Hay, D. I. Abouelazm, and E. R. Said, “Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment: A Dermoscopic Evaluation,” Dermatologic Surgery 48, no. 5 (2022): 556–561.
|
| [50] |
S. Katiyar and D. Yadav, “Correlation of Oxidative Stress With Melasma: An Overview,” Current Pharmaceutical Design 28, no. 3 (2022): 225–231.
|
| [51] |
I. Prudovsky, D. Carter, D. Kacer, et al., “Tranexamic Acid Suppresses the Release of Mitochondrial DNA, Protects the Endothelial Monolayer and Enhances Oxidative Phosphorylation,” Journal of Cellular Physiology 234, no. 11 (2019): 19121–19129.
|
| [52] |
D. Nii, A. C. Esposito, G. Peres, et al., “Tinted Sunscreens Lead to a Smaller Amount of the Product Applied on the Face[J],” International Journal of Dermatology 59, no. 12 (2020): e438–e439.
|
RIGHTS & PERMISSIONS
2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.
PDF
